Epic Research Update : Sun Pharma Q2

Cons Net Profit At Rs 1,572 Cr Vs Rs 1,362 Cr (YoY)

Cons Revenue At Rs 4,769 Cr Vs Rs 4,207 Cr (YoY)

Cons EBITDA At Rs 2,180 Cr Vs Rs 1,843 Cr (YoY)

Cons Operating Margin At 45.7% Vs 43.8% (YoY)



Real Time News & Trading Trends Keep Liking #EpicResearch



Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips